Cassava Presents Promising Preclinical Simufilam Data at TSC Alliance Meeting
AUSTIN, Texas -- Cassava Sciences, Inc., a clinical-stage biotechnology company focused on developing novel, investigational treatments for central nervous system (CNS) disorders,